Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-26-019606
Filing Date
2026-03-18
Accepted
2026-03-18 20:48:38
Documents
4
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1773881313.html 3  
1 FORM 3 wk-form3_1773881313.xml 3 2748
2 EX-24 mariepoa.htm EX-24 5823
3 GRAPHIC mariepoa001.jpg GRAPHIC 238254
4 GRAPHIC mariepoa002.jpg GRAPHIC 119834
  Complete submission text file 0001628280-26-019606.txt   503461
Mailing Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051
Business Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 61 3 9093 3855
Telix Pharmaceuticals Ltd (Issuer) CIK: 0002007191 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 55 FLEMINGTON ROAD, LEVEL 4 NORTH MELBOURNE VICTORIA Australia 3051
Business Address
McDonald Marie Elizabeth (Reporting) CIK: 0002120369 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42128 | Film No.: 26771862